Copyright Reports & Markets. All rights reserved.

Global and United States Lung Cancer Therapeutics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Lung Cancer Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Chemotherapy
    • 1.2.3 Targeted therapy
    • 1.2.4 Drugs
    • 1.2.5 Surgery
    • 1.2.6 Radiotherapy
  • 1.3 Market by Application
    • 1.3.1 Global Lung Cancer Therapeutics Market Share by Application: 2020 VS 2026
    • 1.3.2 Treatment Of Early And Middle Lung Cancer
    • 1.3.3 Treatment Of Advanced Lung Cancer
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Lung Cancer Therapeutics Market Perspective (2015-2026)
  • 2.2 Global Lung Cancer Therapeutics Growth Trends by Regions
    • 2.2.1 Lung Cancer Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Lung Cancer Therapeutics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Lung Cancer Therapeutics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Lung Cancer Therapeutics Players by Market Size
    • 3.1.1 Global Top Lung Cancer Therapeutics Players by Revenue (2015-2020)
    • 3.1.2 Global Lung Cancer Therapeutics Revenue Market Share by Players (2015-2020)
  • 3.2 Global Lung Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Lung Cancer Therapeutics Revenue
  • 3.4 Global Lung Cancer Therapeutics Market Concentration Ratio
    • 3.4.1 Global Lung Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Therapeutics Revenue in 2019
  • 3.5 Key Players Lung Cancer Therapeutics Area Served
  • 3.6 Key Players Lung Cancer Therapeutics Product Solution and Service
  • 3.7 Date of Enter into Lung Cancer Therapeutics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Therapeutics Breakdown Data by Type (2015-2026)

  • 4.1 Global Lung Cancer Therapeutics Historic Market Size by Type (2015-2020)
  • 4.2 Global Lung Cancer Therapeutics Forecasted Market Size by Type (2021-2026)

5 Lung Cancer Therapeutics Breakdown Data by Application (2015-2026)

  • 5.1 Global Lung Cancer Therapeutics Historic Market Size by Application (2015-2020)
  • 5.2 Global Lung Cancer Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Lung Cancer Therapeutics Market Size (2015-2026)
  • 6.2 North America Lung Cancer Therapeutics Market Size by Type (2015-2020)
  • 6.3 North America Lung Cancer Therapeutics Market Size by Application (2015-2020)
  • 6.4 North America Lung Cancer Therapeutics Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Lung Cancer Therapeutics Market Size (2015-2026)
  • 7.2 Europe Lung Cancer Therapeutics Market Size by Type (2015-2020)
  • 7.3 Europe Lung Cancer Therapeutics Market Size by Application (2015-2020)
  • 7.4 Europe Lung Cancer Therapeutics Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Lung Cancer Therapeutics Market Size (2015-2026)
  • 8.2 China Lung Cancer Therapeutics Market Size by Type (2015-2020)
  • 8.3 China Lung Cancer Therapeutics Market Size by Application (2015-2020)
  • 8.4 China Lung Cancer Therapeutics Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Lung Cancer Therapeutics Market Size (2015-2026)
  • 9.2 Japan Lung Cancer Therapeutics Market Size by Type (2015-2020)
  • 9.3 Japan Lung Cancer Therapeutics Market Size by Application (2015-2020)
  • 9.4 Japan Lung Cancer Therapeutics Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Lung Cancer Therapeutics Market Size (2015-2026)
  • 10.2 Southeast Asia Lung Cancer Therapeutics Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Lung Cancer Therapeutics Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Lung Cancer Therapeutics Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Pfizer
    • 11.1.1 Pfizer Company Details
    • 11.1.2 Pfizer Business Overview
    • 11.1.3 Pfizer Lung Cancer Therapeutics Introduction
    • 11.1.4 Pfizer Revenue in Lung Cancer Therapeutics Business (2015-2020))
    • 11.1.5 Pfizer Recent Development
  • 11.2 Roche
    • 11.2.1 Roche Company Details
    • 11.2.2 Roche Business Overview
    • 11.2.3 Roche Lung Cancer Therapeutics Introduction
    • 11.2.4 Roche Revenue in Lung Cancer Therapeutics Business (2015-2020)
    • 11.2.5 Roche Recent Development
  • 11.3 Merck
    • 11.3.1 Merck Company Details
    • 11.3.2 Merck Business Overview
    • 11.3.3 Merck Lung Cancer Therapeutics Introduction
    • 11.3.4 Merck Revenue in Lung Cancer Therapeutics Business (2015-2020)
    • 11.3.5 Merck Recent Development
  • 11.4 AstraZeneca
    • 11.4.1 AstraZeneca Company Details
    • 11.4.2 AstraZeneca Business Overview
    • 11.4.3 AstraZeneca Lung Cancer Therapeutics Introduction
    • 11.4.4 AstraZeneca Revenue in Lung Cancer Therapeutics Business (2015-2020)
    • 11.4.5 AstraZeneca Recent Development
  • 11.5 Sanofi-Aventis
    • 11.5.1 Sanofi-Aventis Company Details
    • 11.5.2 Sanofi-Aventis Business Overview
    • 11.5.3 Sanofi-Aventis Lung Cancer Therapeutics Introduction
    • 11.5.4 Sanofi-Aventis Revenue in Lung Cancer Therapeutics Business (2015-2020)
    • 11.5.5 Sanofi-Aventis Recent Development
  • 11.6 Eli Lilly and Company
    • 11.6.1 Eli Lilly and Company Company Details
    • 11.6.2 Eli Lilly and Company Business Overview
    • 11.6.3 Eli Lilly and Company Lung Cancer Therapeutics Introduction
    • 11.6.4 Eli Lilly and Company Revenue in Lung Cancer Therapeutics Business (2015-2020)
    • 11.6.5 Eli Lilly and Company Recent Development
  • 11.7 Abbott
    • 11.7.1 Abbott Company Details
    • 11.7.2 Abbott Business Overview
    • 11.7.3 Abbott Lung Cancer Therapeutics Introduction
    • 11.7.4 Abbott Revenue in Lung Cancer Therapeutics Business (2015-2020)
    • 11.7.5 Abbott Recent Development
  • 11.8 Akebia Therapeutics
    • 11.8.1 Akebia Therapeutics Company Details
    • 11.8.2 Akebia Therapeutics Business Overview
    • 11.8.3 Akebia Therapeutics Lung Cancer Therapeutics Introduction
    • 11.8.4 Akebia Therapeutics Revenue in Lung Cancer Therapeutics Business (2015-2020)
    • 11.8.5 Akebia Therapeutics Recent Development
  • 11.9 Agennix AG
    • 11.9.1 Agennix AG Company Details
    • 11.9.2 Agennix AG Business Overview
    • 11.9.3 Agennix AG Lung Cancer Therapeutics Introduction
    • 11.9.4 Agennix AG Revenue in Lung Cancer Therapeutics Business (2015-2020)
    • 11.9.5 Agennix AG Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Lung Cancer Therapeutics Scope and Market Size
    Lung Cancer Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lung Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Chemotherapy
    Targeted therapy
    Drugs
    Surgery
    Radiotherapy

    Market segment by Application, split into
    Treatment Of Early And Middle Lung Cancer
    Treatment Of Advanced Lung Cancer

    Based on regional and country-level analysis, the Lung Cancer Therapeutics market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Lung Cancer Therapeutics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Pfizer
    Roche
    Merck
    AstraZeneca
    Sanofi-Aventis
    Eli Lilly and Company
    Abbott
    Akebia Therapeutics
    Agennix AG

    Buy now